,,ii  #aahth ,,congress  #ast ,session  
,s4 #fdd  ,,in ,,the ,,senate ,,of ,,the
 ,,united ,,states  ,march #b1 #bjbc,mr4
 ,markey 7for himself1 ,mr4 ,paul1 ,mr4 
,sanders1 ,mr4 ,braun1 ,mr4 ,booker1 and
 ,ms4 ,hassan7 introduced the following 
bill2 which was read twice and referred 
to the ,committee on ,health1           
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to expand the take-home        
prescribing of methadone through        
pharmacies4  #a4 ,short title ,this ,act
 may be cited as the ,modernizing       
,opioid ,treatment ,access ,act4  #b4   
,expansion of methadone for opioid use  
disorder through prescribing and        
pharmacies  7a7 ,registration2 other    
care by telehealth  7#a7 ,definitions   
,in this subsection3 7,a7 ,controlled   
substance2 detoxification treatment2    
dispense2 maintenance treatment2 opioid 
,the terms controlled substance1        
detoxification treatment1 dispense1     
maintenance treatment1 and opioid have  
the meanings given the terms in section 

#ajb of the ,controlled ,substances ,act
 7#ba ,u4,s4,c4 #hjb74  7,b7 ,secretary 
,the term ,secretary means the          
,secretary of ,health and ,human        
,services4  7#b7 ,waiver  7,a7 ,in      
general ,the requirements of section    
#cjc7;h7 of ,controlled ,substances ,act
 7#ba ,u4,s4,c4 #hbc7;h77 applicable to 
methadone medication for opioid use     
disorder are waived1 and the ,attorney  
,general1 in consultation with the      
,secretary1 shall register persons      
described in subparagraph 7,b7 to       
prescribe methadone for opioid use      
disorder to be dispensed through a      
pharmacy for individuals for            
unsupervised use4  7,b7 ,persons        
described ,persons described in this    
subparagraph are persons who-- 7i7 are  
licensed1 registered1 or otherwise      
permitted1 by the ,united ,states or the
 jurisdiction in which they practice1 to
 prescribe controlled substances in the 
course of professional practice2 and    
7ii7 are-- 7,i7 employees or contractors

 of an opioid treatment program2 or     
7,,ii7 addiction medicine physicians or 
addiction psychiatrists who hold a      
subspecialty board certification in     
addiction medicine from the ,american   
,board of ,preventive ,medicine1 a board
 certification in addiction medicine    
from the ,american ,board of ,addiction 
,medicine1 a subspecialty board         
certification in addiction psychiatry   
from the ,american ,board of ,psychiatry
 and ,neurology1 or a subspecialty board
 certification in addiction medicine    
from the ,american ,osteopathic         
,association4  7,c7 ,requirements for   
prescribing methadone ,the prescribing  
of methadone pursuant to subparagraph   
7,a7 shall be-- 7i7 exclusively by      
electronic prescribing and dispensed to 
the patient treated pursuant to         
subparagraph 7,a72  7ii7 for a supply of
 not more than #cj days pursuant to each
 prescription2 and  7iii7 subject to the
 restrictions listed in section         
#h4ab7;i77#c7 of title #db1 ,code of    

,federal ,regulations1 or successor     
regulation or guidance4  7,d7           
,requirements for dispensing methadone  
,the dispensing of methadone to an      
individual pursuant to subparagraph 7,a7
 shall be in addition to the other care 
that the individual continues to have   
access to through an opioid treatment   
program4  7,e7 ,registration            
requirements ,persons registered in a   
,state pursuant to subparagraph 7,a7    
shall-- 7i7 ensure and document1 with   
respect to each patient treated pursuant
 to subparagraph 7,a71 informed consent 
to treatment2 and  7ii7 include in such 
informed consent1 specific informed     
consent regarding differences in        
confidentiality protections applicable  
when dispensing through an opioid       
treatment program versus dispensing     
through a pharmacy pursuant to          
subparagraph 7,a74  7,f7 ,cessation and 
withdrawal of registration ,at the      
request of a ,state1 the ,attorney      
,general1 in consultation with the      

,secretary1 shall-- 7i7 cease           
registering persons in the ,state       
pursuant to subparagraph 7,a72 and  7ii7
 withdraw any such registration in      
effect for a person in the ,state4  7,g7
 ,maintenance and detoxification        
treatment ,maintenance treatment or     
detoxification treatment provided       
pursuant to subparagraph 7,a7 and other 
care provided in conjunction with such  
treatment1 such as counseling and other 
ancillary services1 may be provided by  
means of telehealth1 as determined      
jointly by the ,state and the ,secretary
 to be feasible and appropriate4  7b7   
,annual reporting ,not later than #ahj  
days after the date of enactment of this
 ,act1 and annually thereafter1 the     
,assistant ,secretary for ,mental       
,health and ,substance ,use and the     
,administrator of the ,drug ,enforcement
 ,administration shall jointly submit a 
report to ,congress that includes-- 7#a7
 the number of persons registered       
pursuant to subsection 7a72  7#b7 the   

number of patients being prescribed     
methadone pursuant to subsection 7a72   
and  7#c7 a list of the ,states in which
 persons are registered pursuant to such
 subsection 7a74  #c4 ,sense of         
,congress on need to reduce barriers to 
patient care through opioid treatment   
programs ,it is the sense of ,congress  
that-- 7#a7 patients receiving services 
through opioid treatment programs face  
barriers to their care2 and  7#b7 each  
,state should align the regulation of   
opioid treatment programs in a manner   
that is consistent with the intent of   
this ,act4